APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hybrid Brain–Computer Interface (hBCI)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Hybrid Brain–Computer Interface (hBCI) Industry Research Report 2026

Report ID 17433004015 July 2026133 pages

Choose your research edition.

Industry ResearchHybrid Brain–Computer Interface (hBCI) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Hybrid Brain–Computer Interface (hBCI) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Hybrid Brain–Computer Interface (hBCI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hybrid Brain–Computer Interface (hBCI) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hybrid Brain–Computer Interface (hBCI) Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Hybrid Brain–Computer Interface (hBCI) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Hybrid Brain–Computer Interface (hBCI) is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Hybrid Brain–Computer Interface (hBCI) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Hybrid Brain–Computer Interface (hBCI) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Hybrid Brain–Computer Interface (hBCI) include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Hybrid Brain–Computer Interface (hBCI) market in revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Hybrid Brain–Computer Interface (hBCI).

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Hybrid Brain–Computer Interface (hBCI) Market by Company

Neuralink

NeuroSky

NeuroPace

EMOTIV

Blackrock Neurotech

Compumedics

Advanced Brain Monitoring

G.TEC

Neuroelectrics

Brain Products

ANT Neuro

BrainCo

Neuracle

Flexolink

NeuralFlex

Hybrid Brain–Computer Interface (hBCI) Segment by Type

Invasive

Non-invasive

Hybrid Brain–Computer Interface (hBCI) Segment by Application

Healthcare

Entertainment and Education

Others

Hybrid Brain–Computer Interface (hBCI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hybrid Brain–Computer Interface (hBCI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hybrid Brain–Computer Interface (hBCI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hybrid Brain–Computer Interface (hBCI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Hybrid Brain–Computer Interface (hBCI) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Hybrid Brain–Computer Interface (hBCI) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Hybrid Brain–Computer Interface (hBCI) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hybrid Brain–Computer Interface (hBCI) Production by Manufacturers (k units) & (2021-2026) Table 6. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Manufacturers Table 7. Global Hybrid Brain–Computer Interface (hBCI) Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Hybrid Brain–Computer Interface (hBCI) Average Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Hybrid Brain–Computer Interface (hBCI) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hybrid Brain–Computer Interface (hBCI) Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Hybrid Brain–Computer Interface (hBCI) Manufacturers, Product Type & Application Table 13. Global Hybrid Brain–Computer Interface (hBCI) Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hybrid Brain–Computer Interface (hBCI) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Neuralink Company Information Table 18. Neuralink Business Overview Table 19. Neuralink Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 20. Neuralink Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 21. Neuralink Recent Development Table 22. NeuroSky Company Information Table 23. NeuroSky Business Overview Table 24. NeuroSky Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 25. NeuroSky Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 26. NeuroSky Recent Development Table 27. NeuroPace Company Information Table 28. NeuroPace Business Overview Table 29. NeuroPace Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 30. NeuroPace Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 31. NeuroPace Recent Development Table 32. EMOTIV Company Information Table 33. EMOTIV Business Overview Table 34. EMOTIV Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 35. EMOTIV Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 36. EMOTIV Recent Development Table 37. Blackrock Neurotech Company Information Table 38. Blackrock Neurotech Business Overview Table 39. Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 40. Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 41. Blackrock Neurotech Recent Development Table 42. Compumedics Company Information Table 43. Compumedics Business Overview Table 44. Compumedics Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Compumedics Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 46. Compumedics Recent Development Table 47. Advanced Brain Monitoring Company Information Table 48. Advanced Brain Monitoring Business Overview Table 49. Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 50. Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 51. Advanced Brain Monitoring Recent Development Table 52. G.TEC Company Information Table 53. G.TEC Business Overview Table 54. G.TEC Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 55. G.TEC Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 56. G.TEC Recent Development Table 57. Neuroelectrics Company Information Table 58. Neuroelectrics Business Overview Table 59. Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 61. Neuroelectrics Recent Development Table 62. Brain Products Company Information Table 63. Brain Products Business Overview Table 64. Brain Products Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. Brain Products Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 66. Brain Products Recent Development Table 67. ANT Neuro Company Information Table 68. ANT Neuro Business Overview Table 69. ANT Neuro Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. ANT Neuro Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 71. ANT Neuro Recent Development Table 72. BrainCo Company Information Table 73. BrainCo Business Overview Table 74. BrainCo Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. BrainCo Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 76. BrainCo Recent Development Table 77. Neuracle Company Information Table 78. Neuracle Business Overview Table 79. Neuracle Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Neuracle Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 81. Neuracle Recent Development Table 82. Flexolink Company Information Table 83. Flexolink Business Overview Table 84. Flexolink Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Flexolink Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 86. Flexolink Recent Development Table 87. NeuralFlex Company Information Table 88. NeuralFlex Business Overview Table 89. NeuralFlex Hybrid Brain–Computer Interface (hBCI) Production (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. NeuralFlex Hybrid Brain–Computer Interface (hBCI) Product Portfolio Table 91. NeuralFlex Recent Development Table 92. Global Hybrid Brain–Computer Interface (hBCI) Production Comparison by Region: 2021 VS 2025 VS 2032 (k units) Table 93. Global Hybrid Brain–Computer Interface (hBCI) Production by Region (2021-2026) & (k units) Table 94. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Region (2021-2026) Table 95. Global Hybrid Brain–Computer Interface (hBCI) Production Forecast by Region (2027-2032) & (k units) Table 96. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share Forecast by Region (2027-2032) Table 97. Global Hybrid Brain–Computer Interface (hBCI) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Global Hybrid Brain–Computer Interface (hBCI) Production Value by Region (2021-2026) & (US$ Million) Table 99. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Region (2021-2026) Table 100. Global Hybrid Brain–Computer Interface (hBCI) Production Value Forecast by Region (2027-2032) & (US$ Million) Table 101. Global Hybrid Brain–Computer Interface (hBCI) Market Average Price (USD/unit) by Region (2021-2026) Table 102. Global Hybrid Brain–Computer Interface (hBCI) Market Average Price (USD/unit) by Region (2027-2032) Table 103. Global Hybrid Brain–Computer Interface (hBCI) Consumption Comparison by Region: 2021 VS 2025 VS 2032 (k units) Table 104. Global Hybrid Brain–Computer Interface (hBCI) Consumption by Region (2021-2026) & (k units) Table 105. Global Hybrid Brain–Computer Interface (hBCI) Consumption Market Share by Region (2021-2026) Table 106. Global Hybrid Brain–Computer Interface (hBCI) Forecasted Consumption by Region (2027-2032) & (k units) Table 107. Global Hybrid Brain–Computer Interface (hBCI) Forecasted Consumption Market Share by Region (2027-2032) Table 108. North America Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 109. North America Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2026) & (k units) Table 110. North America Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2027-2032) & (k units) Table 111. Europe Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 112. Europe Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2026) & (k units) Table 113. Europe Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2027-2032) & (k units) Table 114. Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 115. Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2026) & (k units) Table 116. Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2027-2032) & (k units) Table 117. South America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 118. South America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2026) & (k units) Table 119. South America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2027-2032) & (k units) Table 120. Global Hybrid Brain–Computer Interface (hBCI) Production by Type (2021-2026) & (k units) Table 121. Global Hybrid Brain–Computer Interface (hBCI) Production by Type (2027-2032) & (k units) Table 122. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Type (2021-2026) Table 123. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Type (2027-2032) Table 124. Global Hybrid Brain–Computer Interface (hBCI) Production Value by Type (2021-2026) & (US$ Million) Table 125. Global Hybrid Brain–Computer Interface (hBCI) Production Value by Type (2027-2032) & (US$ Million) Table 126. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Type (2021-2026) Table 127. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Type (2027-2032) Table 128. Global Hybrid Brain–Computer Interface (hBCI) Price by Type (2021-2026) & (USD/unit) Table 129. Global Hybrid Brain–Computer Interface (hBCI) Price by Type (2027-2032) & (USD/unit) Table 130. Global Hybrid Brain–Computer Interface (hBCI) Production by Application (2021-2026) & (k units) Table 131. Global Hybrid Brain–Computer Interface (hBCI) Production by Application (2027-2032) & (k units) Table 132. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Application (2021-2026) Table 133. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Application (2027-2032) Table 134. Global Hybrid Brain–Computer Interface (hBCI) Production Value by Application (2021-2026) & (US$ Million) Table 135. Global Hybrid Brain–Computer Interface (hBCI) Production Value by Application (2027-2032) & (US$ Million) Table 136. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Application (2021-2026) Table 137. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Application (2027-2032) Table 138. Global Hybrid Brain–Computer Interface (hBCI) Price by Application (2021-2026) & (USD/unit) Table 139. Global Hybrid Brain–Computer Interface (hBCI) Price by Application (2027-2032) & (USD/unit) Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Hybrid Brain–Computer Interface (hBCI) Distributors List Table 143. Hybrid Brain–Computer Interface (hBCI) Customers List Table 144. Hybrid Brain–Computer Interface (hBCI) Industry Trends Table 145. Hybrid Brain–Computer Interface (hBCI) Industry Drivers Table 146. Hybrid Brain–Computer Interface (hBCI) Industry Restraints Table 147. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Hybrid Brain–Computer Interface (hBCI) Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Invasive Product Image Figure 7. Non-invasive Product Image Figure 8. Healthcare Product Image Figure 9. Entertainment and Education Product Image Figure 10. Others Product Image Figure 11. Global Hybrid Brain–Computer Interface (hBCI) Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Hybrid Brain–Computer Interface (hBCI) Production Value (2021-2032) & (US$ Million) Figure 13. Global Hybrid Brain–Computer Interface (hBCI) Production Capacity (2021-2032) & (k units) Figure 14. Global Hybrid Brain–Computer Interface (hBCI) Production (2021-2032) & (k units) Figure 15. Global Hybrid Brain–Computer Interface (hBCI) Average Price (USD/unit) & (2021-2032) Figure 16. Global Hybrid Brain–Computer Interface (hBCI) Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Hybrid Brain–Computer Interface (hBCI) Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Hybrid Brain–Computer Interface (hBCI) Production Comparison by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Hybrid Brain–Computer Interface (hBCI) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Hybrid Brain–Computer Interface (hBCI) Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe Hybrid Brain–Computer Interface (hBCI) Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China Hybrid Brain–Computer Interface (hBCI) Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan Hybrid Brain–Computer Interface (hBCI) Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. South Korea Hybrid Brain–Computer Interface (hBCI) Production Value (US$ Million) Growth Rate (2021-2032) Figure 28. Global Hybrid Brain–Computer Interface (hBCI) Consumption Comparison by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Hybrid Brain–Computer Interface (hBCI) Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 31. North America Hybrid Brain–Computer Interface (hBCI) Consumption Market Share by Country (2021-2032) Figure 32. United States Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 33. United States Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 34. Canada Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 35. Mexico Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 36. Europe Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 37. Europe Hybrid Brain–Computer Interface (hBCI) Consumption Market Share by Country (2021-2032) Figure 38. Germany Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 39. France Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 40. U.K. Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 41. Italy Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 42. Russia Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 43. Spain Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 44. Netherlands Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 45. Switzerland Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 46. Sweden Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 47. Poland Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 48. Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 49. Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption Market Share by Country (2021-2032) Figure 50. China Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 51. Japan Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 52. South Korea Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 53. India Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 54. Australia Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 55. Taiwan Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 56. Southeast Asia Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 57. South America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 58. South America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption Market Share by Country (2021-2032) Figure 59. Brazil Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 60. Argentina Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 61. Chile Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 62. Turkey Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 63. GCC Countries Hybrid Brain–Computer Interface (hBCI) Consumption and Growth Rate (2021-2032) & (k units) Figure 64. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Type (2021-2032) Figure 65. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Type (2021-2032) Figure 66. Global Hybrid Brain–Computer Interface (hBCI) Price (USD/unit) by Type (2021-2032) Figure 67. Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Application (2021-2032) Figure 68. Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Application (2021-2032) Figure 69. Global Hybrid Brain–Computer Interface (hBCI) Price (USD/unit) by Application (2021-2032) Figure 70. Hybrid Brain–Computer Interface (hBCI) Value Chain Figure 71. Hybrid Brain–Computer Interface (hBCI) Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Hybrid Brain–Computer Interface (hBCI) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Invasive
  • Non-invasive
Applications
  • Healthcare
  • Entertainment and Education
  • Others
Companies covered
  • Neuralink
  • NeuroSky
  • NeuroPace
  • EMOTIV
  • Blackrock Neurotech
  • Compumedics
  • Advanced Brain Monitoring
  • G.TEC
  • Neuroelectrics
  • Brain Products
  • ANT Neuro
  • BrainCo
  • Neuracle
  • Flexolink
  • NeuralFlex

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Hybrid Brain–Computer Interface (hBCI) by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Invasive
  5. 2.2.3 Non-invasive
  6. 2.3 Hybrid Brain–Computer Interface (hBCI) by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Healthcare
  9. 2.3.3 Entertainment and Education
  10. 2.3.4 Others
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global Hybrid Brain–Computer Interface (hBCI) Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global Hybrid Brain–Computer Interface (hBCI) Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global Hybrid Brain–Computer Interface (hBCI) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Manufacturers (2021-2026)
  2. 3.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Hybrid Brain–Computer Interface (hBCI) Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Hybrid Brain–Computer Interface (hBCI) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hybrid Brain–Computer Interface (hBCI) Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Hybrid Brain–Computer Interface (hBCI) Manufacturers, Product Type & Application
  7. 3.7 Global Hybrid Brain–Computer Interface (hBCI) Manufacturers Established Date
  8. 3.8 Global Hybrid Brain–Computer Interface (hBCI) Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Neuralink
  2. 4.1.1 Neuralink Hybrid Brain–Computer Interface (hBCI) Company Information
  3. 4.1.2 Neuralink Hybrid Brain–Computer Interface (hBCI) Business Overview
  4. 4.1.3 Neuralink Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  5. 4.1.4 Neuralink Product Portfolio
  6. 4.1.5 Neuralink Recent Developments
  7. 4.2 NeuroSky
  8. 4.2.1 NeuroSky Hybrid Brain–Computer Interface (hBCI) Company Information
  9. 4.2.2 NeuroSky Hybrid Brain–Computer Interface (hBCI) Business Overview
  10. 4.2.3 NeuroSky Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  11. 4.2.4 NeuroSky Product Portfolio
  12. 4.2.5 NeuroSky Recent Developments
  13. 4.3 NeuroPace
  14. 4.3.1 NeuroPace Hybrid Brain–Computer Interface (hBCI) Company Information
  15. 4.3.2 NeuroPace Hybrid Brain–Computer Interface (hBCI) Business Overview
  16. 4.3.3 NeuroPace Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  17. 4.3.4 NeuroPace Product Portfolio
  18. 4.3.5 NeuroPace Recent Developments
  19. 4.4 EMOTIV
  20. 4.4.1 EMOTIV Hybrid Brain–Computer Interface (hBCI) Company Information
  21. 4.4.2 EMOTIV Hybrid Brain–Computer Interface (hBCI) Business Overview
  22. 4.4.3 EMOTIV Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  23. 4.4.4 EMOTIV Product Portfolio
  24. 4.4.5 EMOTIV Recent Developments
  25. 4.5 Blackrock Neurotech
  26. 4.5.1 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Company Information
  27. 4.5.2 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Business Overview
  28. 4.5.3 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  29. 4.5.4 Blackrock Neurotech Product Portfolio
  30. 4.5.5 Blackrock Neurotech Recent Developments
  31. 4.6 Compumedics
  32. 4.6.1 Compumedics Hybrid Brain–Computer Interface (hBCI) Company Information
  33. 4.6.2 Compumedics Hybrid Brain–Computer Interface (hBCI) Business Overview
  34. 4.6.3 Compumedics Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  35. 4.6.4 Compumedics Product Portfolio
  36. 4.6.5 Compumedics Recent Developments
  37. 4.7 Advanced Brain Monitoring
  38. 4.7.1 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Company Information
  39. 4.7.2 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Business Overview
  40. 4.7.3 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  41. 4.7.4 Advanced Brain Monitoring Product Portfolio
  42. 4.7.5 Advanced Brain Monitoring Recent Developments
  43. 4.8 G.TEC
  44. 4.8.1 G.TEC Hybrid Brain–Computer Interface (hBCI) Company Information
  45. 4.8.2 G.TEC Hybrid Brain–Computer Interface (hBCI) Business Overview
  46. 4.8.3 G.TEC Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  47. 4.8.4 G.TEC Product Portfolio
  48. 4.8.5 G.TEC Recent Developments
  49. 4.9 Neuroelectrics
  50. 4.9.1 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Company Information
  51. 4.9.2 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Business Overview
  52. 4.9.3 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  53. 4.9.4 Neuroelectrics Product Portfolio
  54. 4.9.5 Neuroelectrics Recent Developments
  55. 4.10 Brain Products
  56. 4.10.1 Brain Products Hybrid Brain–Computer Interface (hBCI) Company Information
  57. 4.10.2 Brain Products Hybrid Brain–Computer Interface (hBCI) Business Overview
  58. 4.10.3 Brain Products Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  59. 4.10.4 Brain Products Product Portfolio
  60. 4.10.5 Brain Products Recent Developments
  61. 4.11 ANT Neuro
  62. 4.11.1 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Company Information
  63. 4.11.2 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Business Overview
  64. 4.11.3 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  65. 4.11.4 ANT Neuro Product Portfolio
  66. 4.11.5 ANT Neuro Recent Developments
  67. 4.12 BrainCo
  68. 4.12.1 BrainCo Hybrid Brain–Computer Interface (hBCI) Company Information
  69. 4.12.2 BrainCo Hybrid Brain–Computer Interface (hBCI) Business Overview
  70. 4.12.3 BrainCo Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  71. 4.12.4 BrainCo Product Portfolio
  72. 4.12.5 BrainCo Recent Developments
  73. 4.13 Neuracle
  74. 4.13.1 Neuracle Hybrid Brain–Computer Interface (hBCI) Company Information
  75. 4.13.2 Neuracle Hybrid Brain–Computer Interface (hBCI) Business Overview
  76. 4.13.3 Neuracle Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  77. 4.13.4 Neuracle Product Portfolio
  78. 4.13.5 Neuracle Recent Developments
  79. 4.14 Flexolink
  80. 4.14.1 Flexolink Hybrid Brain–Computer Interface (hBCI) Company Information
  81. 4.14.2 Flexolink Hybrid Brain–Computer Interface (hBCI) Business Overview
  82. 4.14.3 Flexolink Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  83. 4.14.4 Flexolink Product Portfolio
  84. 4.14.5 Flexolink Recent Developments
  85. 4.15 NeuralFlex
  86. 4.15.1 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Company Information
  87. 4.15.2 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Business Overview
  88. 4.15.3 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Production, Value and Gross Margin (2021-2026)
  89. 4.15.4 NeuralFlex Product Portfolio
  90. 4.15.5 NeuralFlex Recent Developments
5 Global Hybrid Brain–Computer Interface (hBCI) Production by Region
  1. 5.1 Global Hybrid Brain–Computer Interface (hBCI) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Hybrid Brain–Computer Interface (hBCI) Production by Region: 2021-2032
  3. 5.2.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Region: 2021-2026
  4. 5.2.2 Global Hybrid Brain–Computer Interface (hBCI) Production Forecast by Region (2027-2032)
  5. 5.3 Global Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Region: 2021-2032
  7. 5.4.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Region: 2021-2026
  8. 5.4.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Hybrid Brain–Computer Interface (hBCI) Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Hybrid Brain–Computer Interface (hBCI) Production and Value, YOY Growth
  11. 5.6.1 North America Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2021-2032)
  15. 5.6.5 South Korea Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2021-2032)
6 Global Hybrid Brain–Computer Interface (hBCI) Consumption by Region
  1. 6.1 Global Hybrid Brain–Computer Interface (hBCI) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hybrid Brain–Computer Interface (hBCI) Consumption by Region (2021-2032)
  3. 6.2.1 Global Hybrid Brain–Computer Interface (hBCI) Consumption by Region: 2021-2026
  4. 6.2.2 Global Hybrid Brain–Computer Interface (hBCI) Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Type (2021-2032)
  2. 7.1.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Type (2021-2032) & (k units)
  3. 7.1.2 Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Type (2021-2032)
  4. 7.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Type (2021-2032)
  5. 7.2.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Hybrid Brain–Computer Interface (hBCI) Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Application (2021-2032)
  2. 8.1.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Application (2021-2032) & (k units)
  3. 8.1.2 Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Application (2021-2032)
  4. 8.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Application (2021-2032)
  5. 8.2.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Hybrid Brain–Computer Interface (hBCI) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Hybrid Brain–Computer Interface (hBCI) Value Chain Analysis
  2. 9.1.1 Hybrid Brain–Computer Interface (hBCI) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Hybrid Brain–Computer Interface (hBCI) Production Mode & Process
  5. 9.2 Hybrid Brain–Computer Interface (hBCI) Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Hybrid Brain–Computer Interface (hBCI) Distributors
  8. 9.2.3 Hybrid Brain–Computer Interface (hBCI) Customers
10 Global Hybrid Brain–Computer Interface (hBCI) Analyzing Market Dynamics
  1. 10.1 Hybrid Brain–Computer Interface (hBCI) Industry Trends
  2. 10.2 Hybrid Brain–Computer Interface (hBCI) Industry Drivers
  3. 10.3 Hybrid Brain–Computer Interface (hBCI) Industry Opportunities and Challenges
  4. 10.4 Hybrid Brain–Computer Interface (hBCI) Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst